The cost of tissue plasminogen activator (tPA), or alteplase, a clot-busting drug used to treat stroke patients, has doubled in the past decade, while reimbursement to hospitals for the use of tPA has ...

Stroke victims treated with TPA were twice as likely to have a good outcome as those who were not. The Food and Drug Administration approved it for stroke the next year, and a move grew to treat ...

Adding either argatroban or eptifibatide to thrombolytic therapy doesn't improve function following an ischemic stroke, results of new research show. "Ultimately, we found no benefit for either ...

Adult patients with sickle cell disease (SCD) who experience a stroke caused by a clot (i.e., ischemic strokes or IS) can be treated safely with tissue plasminogen activator (tPA) if they qualify, ...

CINCINNATI, Ohio. (Ivanhoe Newswire) - Stroke, it’s the leading cause of death for Americans. Every 40 seconds someone will suffer from one. There are two types…ischemic and hemorrhagic. In an ...

A phase 2 study has suggested that the glycoprotein (gp) IIb/IIIa blocker eptifibatide can be safely combined with a reduced dose of tPA in the treatment of acute ischemic stroke, and there was a ...

HUDSON — Columbia Memorial Hospital has a new way to fight strokes. The hospital is using a new clot-busting drug known as Tissue Plasminogen Activator, or TPA. The New York state Department of Health ...

Biomed's NA-911 represents a breakthrough in stroke treatment, focusing on neurogenesis showing potential in the treatment of stroke and facilitating recovery. NA-911 marks a significant breakthrough ...

LONDON (Reuters) - A clot-busting drug routinely given to heart attack patients is safe and effective for treating stroke and can reduce disability if it is given to patients quickly, scientists said ...